Detalles de la búsqueda
1.
Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy.
Int J Mol Sci
; 25(3)2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338777
2.
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Breast Cancer Res Treat
; 190(1): 103-109, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453206
3.
Laryngeal adenoid cystic carcinoma: Radical or conservative surgery?
Am J Otolaryngol
; 42(4): 102974, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33652330
4.
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
Breast Cancer Res
; 22(1): 83, 2020 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758299
5.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
BMC Cancer
; 17(1): 493, 2017 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28724419
6.
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study.
Drugs Context
; 132024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332945
7.
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
J Pers Med
; 12(5)2022 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35629102
8.
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
Drugs Context
; 112022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36118250
9.
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study.
Ther Adv Med Oncol
; 13: 1758835920987651, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33796150
10.
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
Clin Breast Cancer
; 21(5): e489-e496, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33342749
11.
Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.
Ther Adv Med Oncol
; 12: 1758835920958355, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32994808
12.
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).
Cancers (Basel)
; 12(10)2020 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053782
13.
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.
Breast Care (Basel)
; 15(1): 30-37, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231495
14.
Palbociclib in metastatic breast cancer: current evidence and real-life data.
Drugs Context
; 8: 212579, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31391852
15.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
Ther Adv Med Oncol
; 11: 1758835919833864, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31210797
16.
18F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy.
Eur J Nucl Med Mol Imaging
; 40(12): 1930-1, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23877634
17.
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.
Oncol Res Treat
; 41(1-2): 8-13, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29402855
18.
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(94): 36720-36721, 2018 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613355
19.
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(61): 31877-31887, 2018 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159129
20.
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(77): 34639-34640, 2018 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30349655